Statistics for Engineering a Novel Antibody-peptide Bispecific Fusion Protein Against MERS-CoV
Total visits
views | |
---|---|
Engineering a Novel Antibody-peptide Bispecific Fusion Protein Against MERS-CoV | 236 |
Total visits per month
views | |
---|---|
May 2024 | 0 |
June 2024 | 0 |
July 2024 | 0 |
August 2024 | 0 |
September 2024 | 1 |
October 2024 | 0 |
November 2024 | 0 |
File Visits
views | |
---|---|
Wang_2019_Engineering.pdf(legacy) | 128 |
Wang_2019_Engineering.pdf | 12 |
Top country views
views | |
---|---|
United States | 172 |
Ireland | 18 |
France | 9 |
Sweden | 9 |
United Kingdom | 6 |
New Zealand | 6 |
India | 4 |
Australia | 3 |
Canada | 2 |
Netherlands | 2 |
Azerbaijan | 1 |
Spain | 1 |
Hungary | 1 |
Iran | 1 |
South Korea | 1 |
Romania | 1 |
Russia | 1 |
Top city views
views | |
---|---|
Fairfax | 51 |
Buffalo | 26 |
Dublin | 19 |
Ashburn | 18 |
Chicago | 16 |
Louisville | 15 |
Redwood City | 13 |
Alameda | 6 |
Auckland | 6 |
Stockholm | 5 |
Mountain View | 4 |
Åkersberga | 4 |
Sydney | 3 |
Amsterdam | 2 |
Andover | 2 |
Des Moines | 2 |
San Diego | 2 |
Short Hills | 2 |
Toronto | 2 |
Baku | 1 |
Bhiwadi | 1 |
Boardman | 1 |
Buftea | 1 |
Cranston | 1 |
Dallas | 1 |
Delhi | 1 |
Khabarovsk | 1 |
Phoenix | 1 |
Rutherford | 1 |
Sacramento | 1 |
Tehran | 1 |